Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ALPMY

Astellas Pharma (PK) (ALPMY)

Astellas Pharma Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:ALPMY
日付受信時刻ニュースソース見出しコード企業名
2023/12/1607 : 53Dow Jones NewsMerck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/12/0108 : 04Dow Jones NewsAstellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority ReviewUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/09/2220 : 02Dow Jones NewsMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits EndpointsUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/08/0723 : 41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/08/0722 : 58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/05/0109 : 57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionUSOTC:ALPMYAstellas Pharma Inc (PK)
2023/01/1000 : 49Dow Jones NewsSelecta Biosciences Shares Rise 11% After Licensing Deal With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
2022/10/2519 : 26Dow Jones NewsTaysha Gene Therapies Shares Soar Premarket on Astellas InvestmentUSOTC:ALPMYAstellas Pharma Inc (PK)
2022/06/2823 : 28Dow Jones NewsSutro Biopharma Shares Rise 24% After Collaboration With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
2022/06/2809 : 37Dow Jones NewsSutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
2022/04/1401 : 31Dow Jones NewsEuropean Commission Approves Drug for Urothelial CancerUSOTC:ALPMYAstellas Pharma Inc (PK)
2021/12/1721 : 37Dow Jones NewsAstellas Pharma, Seagen Get CHMP Positive Opinion for PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
2021/08/1120 : 54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseUSOTC:ALPMYAstellas Pharma Inc (PK)
2017/12/2206 : 17Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:ALPMYAstellas Pharma Inc (PK)
2017/09/3002 : 03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:ALPMYAstellas Pharma Inc (PK)
2016/08/2221 : 50Dow Jones NewsPfizer Adds Key Cancer Drug in $14 Billion Biotech DealUSOTC:ALPMYAstellas Pharma Inc (PK)
2016/07/0916 : 02Dow Jones NewsCorrections & Amplifications -- WSJUSOTC:ALPMYAstellas Pharma Inc (PK)
2016/07/0714 : 20Dow Jones NewsTest Aids Prostate Cancer TreatmentUSOTC:ALPMYAstellas Pharma Inc (PK)
2016/06/0207 : 40Dow Jones NewsSanofi Asks for Record Date for Vote on Medivation's BoardUSOTC:ALPMYAstellas Pharma Inc (PK)
2016/04/2907 : 10Dow Jones NewsDrugmakers Place Big Bets on Cancer MedicinesUSOTC:ALPMYAstellas Pharma Inc (PK)
2016/03/2923 : 50Dow Jones NewsLawmakers Target Medivation Over Drug PricesUSOTC:ALPMYAstellas Pharma Inc (PK)
2015/12/0506 : 03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyUSOTC:ALPMYAstellas Pharma Inc (PK)
2015/11/2523 : 04The Motley FoolJohnson & Johnson's Latest FDA Approval Could Spell Problems for AmgenUSOTC:ALPMYAstellas Pharma Inc (PK)
2015/11/2400 : 07The Motley Fool3 Value Stocks Near 52-Week Lows Worth BuyingUSOTC:ALPMYAstellas Pharma Inc (PK)
2015/11/0702 : 40The Motley FoolMedivation Inc is Down Today -- But Why?USOTC:ALPMYAstellas Pharma Inc (PK)
2015/11/0221 : 34The Motley Fool3 Stocks to Buy Now in BiotechUSOTC:ALPMYAstellas Pharma Inc (PK)
2015/07/1603 : 33Dow Jones NewsAsian Shares: China Stocks Tumble as Investors Doubt Beijing's HelpUSOTC:ALPMYAstellas Pharma Inc. ADR
2015/03/2220 : 01The Motley FoolBest One-Drug Wonder Stock for 2015USOTC:ALPMYAstellas Pharma Inc (PK)
2015/01/3013 : 30Dow Jones NewsValeant to Buy Prostate-Cancer Drug From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
2015/01/3013 : 10Dow Jones NewsValeant in Deal to Buy Prostate-Cancer Drug Provenge From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
 Showing the most relevant articles for your search:USOTC:ALPMY

最近閲覧した銘柄